If everyone expects the H1 results to outperform, then the outperformance is already priced in. In fact, anything short of having significant operating cash flow increase + confirmation of projected earnings + satisfying report on expected NPAT + booming sales in UK and USA will likely trigger a share price fall. Very very little room for error!
Focus on H1 Result Due in Feb, page-31
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.37 |
Change
0.000(0.00%) |
Mkt cap ! $4.612B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1603 | $6.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.07 | 635 | 1 |
View Market Depth
| Last trade - 09.44am 08/10/2024 (20 minute delay) ? |
| A2M (ASX) Chart |
Day chart unavailable